Abrahamowicz M - Search Results

1

Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study.

Moura CS, Abrahamowicz M, Beauchamp ME, Lacaille D, Wang Y, Boire G, Fortin PR, Bessette L, Bombardier C, Widdifield J, Hanly JG, Feldman D, Maksymowych W, Peschken C, Barnabe C, Edworthy S, Bernatsky S; CAN-AIM. Moura CS, et al. Among authors: abrahamowicz m. Arthritis Res Ther. 2015 Aug 3;17(1):197. doi: 10.1186/s13075-015-0713-3. Arthritis Res Ther. 2015. PMID: 26235697 Free PMC article.

2

Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory tests.

Fortin PR, Abrahamowicz M, Danoff D. Fortin PR, et al. Among authors: abrahamowicz m. J Rheumatol. 1995 Nov;22(11):2078-83. J Rheumatol. 1995. PMID: 8596148

3

The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials.

Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH. Abrahamowicz M, et al. J Rheumatol. 1998 Feb;25(2):277-84. J Rheumatol. 1998. PMID: 9489819

4

Impact of disease activity and cumulative damage on the health of lupus patients.

Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D. Fortin PR, et al. Among authors: abrahamowicz m. Lupus. 1998;7(2):101-7. doi: 10.1191/096120398678919813. Lupus. 1998. PMID: 9541094

5

Do lupus disease activity measures detect clinically important change?

Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, Liang MH. Fortin PR, et al. Among authors: abrahamowicz m. J Rheumatol. 2000 Jun;27(6):1421-8. J Rheumatol. 2000. PMID: 10852264 Clinical Trial.

6

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL. Esdaile JM, et al. Among authors: abrahamowicz m. Arthritis Rheum. 2001 Oct;44(10):2331-7. doi: 10.1002/1529-0131(200110)44:10<2331::aid-art395>3.0.co;2-i. Arthritis Rheum. 2001. PMID: 11665973 Free article.

7

Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.

Chang E, Abrahamowicz M, Ferland D, Fortin PR; CaNIOS Investigators. Chang E, et al. Among authors: abrahamowicz m. J Clin Epidemiol. 2002 May;55(5):488-97. doi: 10.1016/s0895-4356(01)00509-1. J Clin Epidemiol. 2002. PMID: 12007552

8

Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.

Chang ER, Abrahamowicz M, Ferland D, Fortin PR. Chang ER, et al. Among authors: abrahamowicz m. J Rheumatol. 2002 Nov;29(11):2350-8. J Rheumatol. 2002. PMID: 12415591

9

Patient-physician discordance in fibromyalgia.

Dobkin PL, De Civita M, Abrahamowicz M, Bernatsky S, Schulz J, Sewitch M, Baron M. Dobkin PL, et al. Among authors: abrahamowicz m. J Rheumatol. 2003 Jun;30(6):1326-34. J Rheumatol. 2003. PMID: 12784410

10

Determinants of discordance between patients and physicians in their assessment of lupus disease activity.

Yen JC, Abrahamowicz M, Dobkin PL, Clarke AE, Battista RN, Fortin PR. Yen JC, et al. Among authors: abrahamowicz m. J Rheumatol. 2003 Sep;30(9):1967-76. J Rheumatol. 2003. PMID: 12966600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters